Akira Tiele

Dr. Akira Tiele

University of Warwick
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2018 in Journal of Sensors
Verified
Journal Article
Open access
PDF file
Akira TieleAkira Tiele
Akira Tiele
SESiavash Esfahani
Siavash Esfahani
James CovingtonJames Covington
James Covington
This article describes the design and development of a low-cost, portable monitoring system for indoor environment quality (IEQ). IEQ is a holistic concept that encompasses elements of indoor air quality (IAQ), indoor lighting quality (ILQ), acoustic comfort, and thermal comfort (temperature and relative humidity). The unit is intended for the monitoring of temperature, humidity, PM2.5, PM10, total VOCs (×3), CO2, CO, illuminance, and sound levels. Experiments were conducted in various environments, including a typical indoor working environment and outdoor pollution, to evaluate the unit’s potential to monitor IEQ parameters. The developed system was successfully able to monitor parameter variations, based on specific events. A custom IEQ index was devised to rate the parameter readings with a simple scoring system to calculate an overall IEQ percentage. The advantages of the proposed system, with respect to commercial units, is associated with better customisation and flexibility to implement a variety of low-cost sensors. Moreover, low-cost sensor modules reduce the overall cost to provide a comprehensive, portable, and real-time monitoring solution. This development facilities researchers and interested enthusiasts to become engaged and proactive in participating in the study, management, and improvement of IEQ.

12 April 2019 in Biosensors
Verified
Journal Article
Open access
PDF file
Akira TieleAkira Tiele
Akira Tiele
AWAlfian Wicaksono
Alfian Wicaksono
JKJiten Kansara
Jiten Kansara
RARamesh Arasaradnam
Ramesh Arasaradnam
James CovingtonJames Covington
James Covington
Early diagnosis of inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), remains a clinical challenge with current tests being invasive and costly. The analysis of volatile organic compounds (VOCs) in exhaled breath and biomarkers in stool (faecal calprotectin (FCP)) show increasing potential as non-invasive diagnostic tools. The aim of this pilot study is to evaluate the efficacy of breath analysis and determine if FCP can be used as an additional non-invasive parameter to supplement breath results, for the diagnosis of IBD. Thirty-nine subjects were recruited (14 CD, 16 UC, 9 controls). Breath samples were analysed using an in-house built electronic nose (Wolf eNose) and commercial gas chromatograph–ion mobility spectrometer (G.A.S. BreathSpec GC-IMS). Both technologies could consistently separate IBD and controls [AUC ± 95%, sensitivity, specificity], eNose: [0.81, 0.67, 0.89]; GC-IMS: [0.93, 0.87, 0.89]. Furthermore, we could separate CD from UC, eNose: [0.88, 0.71, 0.88]; GC-IMS: [0.71, 0.86, 0.62]. Including FCP did not improve distinction between CD vs. UC; eNose: [0.74, 1.00, 0.56], but rather, improved separation of CD vs. controls and UC vs. controls; eNose: [0.77, 0.55, 1.00] and [0.72, 0.89, 0.67] without FCP, [0.81, 0.73, 0.78] and [0.90, 1.00, 0.78] with FCP, respectively. These results confirm the utility of breath analysis to distinguish between IBD-related diagnostic groups. FCP does not add significant diagnostic value to breath analysis within this study.

14 February 2020 in Journal of Breath Research
Verified
Journal Article
Open access
PDF file
Akira TieleAkira Tiele
Akira Tiele
AWAlfian Wicaksono
Alfian Wicaksono
EDEmma Daulton
Emma Daulton
EIEmmanuel Ifeachor
Emmanuel Ifeachor
VEVictoria Eyre
Victoria Eyre
XLXinzhong Li
Xinzhong Li
Early detection of Alzheimer’s disease (AD) will help researchers to better understand the disease and develop improved treatments. Recent developments have thus focused on identifying biomarkers for mild cognitive impairment due to AD (MCI) and AD during the preclinical phase. The aim of this pilot study is to determine whether exhaled volatile organic compounds (VOCs) can be used as a non-invasive method to distinguish controls from MCI, controls from AD and to determine whether there are differences between MCI and AD. The study used gas chromatography—ion mobility spectrometry (GC-IMS) techniques. Confounding factors, such as age, smoking habits, gender and alcohol consumption are investigated to demonstrate the efficacy of results. One hundred subjects were recruited including 50 controls, 25 AD and 25 MCI patients. The subject cohort was age- and gender-matched to minimise bias. Breath samples were analysed using a commercial GC-IMS instrument (G.A.S. BreathSpec, Dortmund, Germany). Data analysis indicates that the GC-IMS signal was consistently able to separate between diagnostic groups [AUC ± 95%, sensitivity, specificity], controls versus MCI: [0.77 (0.64–0.90), 0.68, 0.80], controls versus AD: [0.83 (0.72–0.94), 0.60, 0.96], and MCI versus AD: [0.70 (0.55–0.85), 0.60, 0.84]. VOC analysis indicates that six compounds play a crucial role in distinguishing between diagnostic groups. Analysis of possible confounding factors indicate that gender, age, smoking habits and alcohol consumption have insignificant influence on breath content. This pilot study confirms the utility of exhaled breath analysis to distinguish between AD, MCI and control subjects. Thus, GC-IMS offers great potential as a non-invasive, high-throughput, diagnostic technique for diagnosing and potentially monitoring AD in a clinical setting.

1 January 2020 in Electronics
Verified
Journal Article
Open access
PDF file
Akira TieleAkira Tiele
Akira Tiele
AWAlfian Wicaksono
Alfian Wicaksono
SASai Kiran Ayyala
Sai Kiran Ayyala
James CovingtonJames Covington
James Covington
In this paper, we report on an in-house developed electronic nose (E-nose) for use with breath analysis. The unit consists of an array of 10 micro-electro-mechanical systems (MEMS) metal oxide (MOX) gas sensors produced by seven manufacturers. Breath sampling of end-tidal breath is achieved using a heated sample tube, capable of monitoring sampling-related parameters, such as carbon dioxide (CO2), humidity, and temperature. A simple mobile app was developed to receive real-time data from the device, using Wi-Fi communication. The system has been tested using chemical standards and exhaled breath samples from healthy volunteers, before and after taking a peppermint capsule. Results from chemical testing indicate that we can separate chemical standards (acetone, isopropanol and 1-propanol) and different concentrations of isobutylene. The analysis of exhaled breath samples demonstrate that we can distinguish between pre- and post-consumption of peppermint capsules; area under the curve (AUC): 0.81, sensitivity: 0.83 (0.59–0.96), specificity: 0.72 (0.47–0.90), p-value: <0.001. The functionality of the developed device has been demonstrated with the testing of chemical standards and a simplified breath study using peppermint capsules. It is our intention to deploy this system in a UK hospital in an upcoming breath research study.

23 July 2020 in Biosensors
Verified
Journal Article
Open access
PDF file
VDValentin-Mihai Dospinescu
Valentin-Mihai Dospinescu
Akira TieleAkira Tiele
Akira Tiele
James CovingtonJames Covington
James Covington
Current available methods for the clinical diagnosis of urinary tract infection (UTI) rely on a urine dipstick test or culturing of pathogens. The dipstick test is rapid (available in 1–2 min), but has a low positive predictive value, while culturing is time-consuming and delays diagnosis (24–72 h between sample collection and pathogen identification). Due to this delay, broad-spectrum antibiotics are often prescribed immediately. The over-prescription of antibiotics should be limited, in order to prevent the development of antimicrobial resistance. As a result, there is a growing need for alternative diagnostic tools. This paper reviews applications of chemical-analysis instruments, such as gas chromatography–mass spectrometry (GC-MS), selected ion flow tube mass spectrometry (SIFT-MS), ion mobility spectrometry (IMS), field asymmetric ion mobility spectrometry (FAIMS) and electronic noses (eNoses) used for the diagnosis of UTI. These methods analyse volatile organic compounds (VOCs) that emanate from the headspace of collected urine samples to identify the bacterial pathogen and even determine the causative agent’s resistance to different antibiotics. There is great potential for these technologies to gain wide-spread and routine use in clinical settings, since the analysis can be automated, and test results can be available within minutes after sample collection. This could significantly reduce the necessity to prescribe broad-spectrum antibiotics and allow the faster and more effective use of narrow-spectrum antibiotics.

1 December 2020 in Sensors
Verified
Journal Article
Open access
PDF file
SESiavash Esfahani
Siavash Esfahani
Akira TieleAkira Tiele
Akira Tiele
SASamuel Agbroko
Samuel Agbroko
James CovingtonJames Covington
James Covington
Electronic nose (E-nose) technology provides an easy and inexpensive way to analyse chemical samples. In recent years, there has been increasing demand for E-noses in applications such as food safety, environmental monitoring and medical diagnostics. Currently, the majority of E-noses utilise an array of metal oxide (MOX) or conducting polymer (CP) gas sensors. However, these sensing technologies can suffer from sensor drift, poor repeatability and temperature and humidity effects. Optical gas sensors have the potential to overcome these issues. This paper reports on the development of an optical non-dispersive infrared (NDIR) E-nose, which consists of an array of four tuneable detectors, able to scan a range of wavelengths (3.1–10.5 μm). The functionality of the device was demonstrated in a series of experiments, involving gas rig tests for individual chemicals (CO2 and CH4), at different concentrations, and discriminating between chemical standards and complex mixtures. The optical gas sensor responses were shown to be linear to polynomial for different concentrations of CO2 and CH4. Good discrimination was achieved between sample groups. Optical E-nose technology therefore demonstrates significant potential as a portable and low-cost solution for a number of E-nose applications.